ClosedPublished 2 Jun 2025

Iris Acquisition Corp /
Liminatus Pharma, LLC

Iris Acquisition Corp completed its deal for Liminatus Pharma, LLC.

Buy side: Iris Acquisition Corp
Buy sideIris Acquisition Corp
Target: Liminatus Pharma, LLC
TargetLiminatus Pharma, LLC
Source · 2 Jun 2025Source-verified
Buy side: Iris Acquisition Corp
Buy sideIris Acquisition Corp
Target: Liminatus Pharma, LLC
TargetLiminatus Pharma, LLC
01 / BuyerIris Acquisition Corp
02 / TargetLiminatus Pharma, LLC
Source-verified
01

What happened

The deal for Liminatus Pharma, LLC has closed, with Iris Acquisition Corp as the buyer, at a stated price of $175.0 million.

The filing from Liminatus Pharma, Inc. is dated June 2, 2025.

02

The source

Everything on this page comes from the source below.

01
Source · Original source

Iris Acquisition Corp completed its deal for Liminatus Pharma, LLC.

This document is the source for the companies, stage, figure and people on this page.

Source-verified
03

Timeline

Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.

  1. Announced

    The source this page is built from.

    Source-verified
  2. Published by the source

    The source this page is built from.

    Source-verified

The same firms, in other deals

The firms' deal history and connections across other deals.

These firms' full profiles are part of Pro.

Request an inviteAlready invited? Sign in

Carrywatch Pro is by invitation. An invite lets you buy Pro.